Search Results - Shida Pan
- Showing 1 - 7 results of 7
List
Grid
-
1Loading…
-
2Loading…
Early Alpha-Fetoprotein Response Predicts Sustained Tumor Response Following Immune Checkpoint Inhibitors Combined with Targeted Therapy in Liver Cancer by Jiahe Tian, Shida Pan, Yilin Wang, Yingying Yu, Siyu Wang, Yingjuan Shen, Luo Yang, Xiaomeng Liu, Qin Qiu, Junqing Luan, Fusheng Wang, Fanping Meng
Published 2024-12-01Get full text
Artigo -
3Loading…
Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinemia: a re... by Shida Pan, Shida Pan, Jianing Wang, Jianing Wang, Jiahe Tian, Jiahe Tian, Yilin Wang, Yilin Wang, Siyu Wang, Yingying Yu, Yingying Yu, Fengyi Li, Yan-Mei Jiao, Yingjuan Shen, Luo Yang, Xiaomeng Liu, Qin Qiu, Junqing Luan, Fu-Sheng Wang, Fu-Sheng Wang, Fu-Sheng Wang, Fu-Sheng Wang, Fanping Meng, Fanping Meng, Fanping Meng
Published 2025-03-01Get full text
Artigo -
4Loading…
Activation of CD14+ Monocytes via the IFN-γ Signaling Pathway Is Associated with Immune-Related Adverse Events in Hepatocellular Carcinoma Patients Receiving PD-1 Inhibition Combin... by Yaoru Song, Shida Pan, Jiahe Tian, Yingying Yu, Siyu Wang, Qin Qiu, Yingjuan Shen, Luo Yang, Xiaomeng Liu, Junqing Luan, Yilin Wang, Jianing Wang, Xing Fan, Fanping Meng, Fu-Sheng Wang
Published 2024-05-01Get full text
Artigo -
5Loading…
Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study by Yilin Wang, Shida Pan, Jiahe Tian, Jianing Wang, Yingying Yu, Siyu Wang, Fengyi Li, Luo Yang, Xiaomeng Liu, Yingjuan Shen, Qin Qiu, Junqing Luan, Mengdie Jia, Chuyue Xiong, Xuanxuan Duan, Fu-Sheng Wang, Fanping Meng
Published 2025-04-01Get full text
Artigo -
6Loading…
Correction: Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hy... by Jianing Wang, Jianing Wang, Shida Pan, Chuyue Xiong, Chuyue Xiong, Jiahe Tian, Jiahe Tian, Yilin Wang, Yingying Yu, Yingying Yu, Siyu Wang, Yingjuan Shen, Luo Yang, Xiaomeng Liu, Junqing Luan, Mengdie Jia, Mengdie Jia, Xuanxuan Duan, Xuanxuan Duan, Fusheng Wang, Fusheng Wang, Fanping Meng, Fanping Meng
Published 2026-04-01Get full text
Artigo -
7Loading…
Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubin... by Jianing Wang, Jianing Wang, Shida Pan, Chuyue Xiong, Chuyue Xiong, Jiahe Tian, Jiahe Tian, Yilin Wang, Yingying Yu, Yingying Yu, Siyu Wang, Yingjuan Shen, Luo Yang, Xiaomeng Liu, Junqing Luan, Mengdie Jia, Mengdie Jia, Xuanxuan Duan, Xuanxuan Duan, Fusheng Wang, Fusheng Wang, Fanping Meng, Fanping Meng
Published 2026-04-01Get full text
Artigo
Search Tools:
Refine Results
Page will reload when a filter is selected or excluded.- Fanping Meng 7 results 7 Exclude matching results
- Shida Pan 7 results 7 Exclude matching results
- Jiahe Tian 6 results 6 Exclude matching results
- Junqing Luan 6 results 6 Exclude matching results
- Luo Yang 6 results 6 Exclude matching results
- Siyu Wang 6 results 6 Exclude matching results
- Xiaomeng Liu 6 results 6 Exclude matching results
- Yilin Wang 6 results 6 Exclude matching results
- Yingjuan Shen 6 results 6 Exclude matching results
- Yingying Yu 6 results 6 Exclude matching results
- Jianing Wang 5 results 5 Exclude matching results
- Fu-Sheng Wang 4 results 4 Exclude matching results
- Qin Qiu 4 results 4 Exclude matching results
- Chuyue Xiong 3 results 3 Exclude matching results
- Fusheng Wang 3 results 3 Exclude matching results
- Mengdie Jia 3 results 3 Exclude matching results
- Xuanxuan Duan 3 results 3 Exclude matching results
- Fengyi Li 2 results 2 Exclude matching results
- Xing Fan 1 results 1 Exclude matching results
- Yan-Mei Jiao 1 results 1 Exclude matching results
- Yang Zhang 1 results 1 Exclude matching results
- Yaoru Song 1 results 1 Exclude matching results
- see all…
